查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球C反應蛋白檢測市場規模、佔有率和行業趨勢分析報告：用途、按檢測類型、按最終用戶、按地區、前景和預測，2023-2030年
市場調查報告書
商品編碼
1353114

全球C反應蛋白檢測市場規模、佔有率和行業趨勢分析報告：用途、按檢測類型、按最終用戶、按地區、前景和預測，2023-2030年

Global C-reactive Protein Testing Market Size, Share & Industry Trends Analysis Report By Application, By Assay Type, By End User (Hospitals & Clinics, Diagnostic Laboratories, and Others), By Regional Outlook and Forecast, 2023 - 2030
出版日期: | 出版商: KBV Research | 英文 268 Pages | 訂單完成後即時交付

價格

C反應蛋白檢測市場規模預計到2030年將達35億美元，預測期內年複合成長率年成長率為2.8%。

此外，COVID-19 的爆發也支持了 C 反應蛋白檢測市場。世界各地的許多診所和醫院都進行了重組，以增加醫院收治新冠肺炎 (COVID-19) 患者的能力。 C反應蛋白（CRP）作為一項重要指標被觀察到在重症COVID-19患者中顯著升高。由於發炎消退時 CRP 濃度會降低，因此它被認為是評估 COVID-19 和肺部病變嚴重程度的有價值的標記。因此，CRP 檢測在 COVID-19 大流行期間激增，顯著提高了市場成長率。

但CRP是發炎的綜合指標。因此，該測試不足以準確診斷所有疾病。因此，它不是一個獨立的診斷測試，這一事實可能會阻礙該市場的成長。磁振造影(MRI)、電腦斷層掃描 (CT) 和超音波影像檢查可以幫助可視化發炎組織，並幫助診斷關節炎、感染疾病和發炎性腸道疾病。由於有許多可用的替代疾病診斷技術，市場擴張可能會受到消費者受歡迎程度的限制。

應用前景

依用途，市場分為糖尿病、類風濕性關節炎、心血管疾病、發炎性腸道疾病等。預計到 2022 年，類類風濕性關節炎領域將在市場中佔據顯著的收入佔有率。 CRP 水平升高以及其他實驗室檢查和臨床評估可以幫助診斷類風濕性關節炎。隨著時間的推移，CRP 水平下降通常表示治療方法有效抑制了 RA 相關發炎。

檢測類型展望

依分析類型，市場分為酵素連結免疫吸附檢測法（ELISA）、化學發光免疫檢測（CLIA）、檢測法等。 2022 年，酵素結合免疫吸附檢測法(ELISA) 領域在市場中獲得了巨大的收入佔有率。以 ELISA檢測樣本中 CRP 的準確濃度，提供定量資料。這樣可以準確監測隨時間的變化，並幫助醫療保健專業人員評估疾病活動和治療反應。由於 ELISA 方法可以設計為對 CRP 具有高度特異性，因此測試結果不太可能受到與血液中其他物質的交叉反應的影響。

最終用戶前景

依最終用戶分類，市場分為醫院/診所、診斷實驗室等。診斷實驗室領域將在 2022 年出現顯著的市場成長率。診斷實驗室對於獸醫疼痛管理至關重要，因為它們為準確診斷、治療計劃和持續監測動物疼痛提供了基礎。它們在改善動物生活品質和福利方面的作用怎麼強調都不為過，它們對獸醫和寵物飼主來說都是寶貴的資源。

區域展望

從區域來看，我們對北美、歐洲、亞太地區和拉丁美洲地區的市場進行了分析。 2022年，北美地區的市佔率最高。即時檢測的便利性和速度是該地區的成長趨勢。 POCT 快速檢測 CRP 有助於及時診斷和治療。北美市場預計將受到技術進步的推動，這些技術進步提高了 CRP 測試的準確性、有效性和可負擔性。在預測期內，北美市場預計將受到發炎疾病日益患病、不健康的生活方式以及用於早期檢測發炎疾病的新檢測套組和解決方案的開拓的推動。

目錄

第1章 市場範圍和調查方法

  • 市場定義
  • 目的
  • 市場範圍
  • 分割
  • 調查方法

第2章 市場概況

  • 主要亮點

第3章 市場概況

  • 介紹
    • 概述
      • 市場結構和情景
  • 影響市場的主要要素
    • 市場促進因素
    • 市場抑制因素
  • 波特五力分析

第4章 全球 C 反應蛋白檢測市場：依用途

  • 全球心血管疾病市場：按地區
  • 全球發炎性腸道疾病市場：按地區
  • 全球類類風濕性關節炎市場：按地區
  • 全球糖尿病市場：按地區
  • 世界其他市場：按地區

第5章 全球 C 反應蛋白檢測市場：依檢測類型

  • 全球免疫比濁法市場：按地區
  • 全球酵素免疫分析法測定 (ELISA) 市場：按地區
  • 全球化學免疫檢測(CLIA) 市場：按地區
  • 世界其他市場：按地區

第6章 全球 C 反應蛋白測試市場：依最終用戶分類

  • 全球醫院和診所市場：按地區
  • 全球診斷實驗室市場：按地區
  • 世界其他市場：按地區

第7章 全球C反應蛋白檢測市場：按地區

  • 北美洲
    • 北美市場：按國家分類
      • 美國
      • 加拿大
      • 墨西哥
      • 其他北美地區
  • 歐洲
    • 歐洲市場：依國家分類
      • 德國
      • 英國
      • 法國
      • 俄羅斯
      • 西班牙
      • 義大利
      • 其他歐洲國家地區
  • 亞太地區
    • 亞太市場：依國家分類
      • 中國
      • 日本
      • 印度
      • 韓國
      • 新加坡
      • 馬來西亞
      • 其他亞太地區
  • 拉丁美洲/中東/非洲
    • 拉丁美洲/中東/非洲市場：依國家分類
      • 巴西
      • 阿根廷
      • 阿拉伯聯合大公國
      • 沙烏地阿拉伯
      • 南非
      • 奈及利亞
      • 其他拉丁美洲/中東/非洲地區

第8章 公司簡介

  • Danaher Corporation
  • F Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc
  • Horiba Ltd
  • Randox Laboratories Limited
  • Zoetis, Inc
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings
  • Merck KGaA

第9章 贏得C反應蛋白檢測市場的必備條件

The Global C-Reactive Protein Testing Market size is expected to reach $3.5 billion by 2030, rising at a market growth of 2.8% CAGR during the forecast period.

Chronic conditions like cardiovascular conditions are associated with high C-reactive protein levels. Therefore, Cardiovascular Disease segment would capture more than 56% share of the market by 2030. The primary factor advancing the expansion of the segment is the rise in the prevalence of CVDs. CRP is a critical marker for identifying CVD by determining the probability of atherosclerosis. Patients with CVDs often have elevated CRP levels, and assays may identify even the lowest amounts of CRP. As a result, the use of CRP testing for the early diagnosis of cardiovascular disorders has dramatically increased, which has caused this segment's revenue to grow throughout the projection period. Some of the Factors impacting the market are increase prevalence of inflammatory diseases, increasing demand for point-of-care testing, and alternative disease-testing techniques are accessible.

This market is projected to expand as inflammatory diseases grow more widespread. The liver produces CRP, an acute-phase protein, in response to tissue damage, infection, or inflammation. The existence of inflammation in the body, which is associated with various illnesses such as cardiovascular disease, rheumatoid arthritis, inflammatory bowel disease, and several types of cancers, may be indicated by elevated levels of CRP in the blood. Overall, the prevalence of inflammatory diseases is on the rise, and CRP testing methods have advanced in technology, which is expected to propel the market. Moreover, POCT is a medical examination carried out near the patient rather than in a centralized laboratory and offers immediate results. POCT for CRP makes testing fast and simple in primary care settings, ERs, and other point-of-care settings, which is especially beneficial for patients who need diagnosis and treatment immediately. This market is predicted to be boosted by increased demand for POCT since it offers a cost-effective and accessible alternative for laboratory testing, which may benefit patients' outcomes and lower healthcare expenditures.

Additionally, The COVID-19 outbreak assisted the market for C-reactive protein testing. In order to boost hospital capacity for patients diagnosed with COVID-19, many clinics and hospitals worldwide were restructured. C-reactive protein (CRP) was observed as a crucial measure that significantly rose among people with severe COVID-19. It was considered a valuable marker for assessing the severity of the disease and lung lesions because its concentration decreases when the inflammatory stages end and the patient heals. As a result, CRP testing surged during the COVID-19 pandemic, considerably increasing market growth.

However, C-reactive protein is a comprehensive indicator of inflammation. As a result, this test is inadequate for accurately diagnosing any illness. Therefore, the fact that it is not a self-sufficient diagnostic test could prevent this market from growing. Imaging studies like magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound can visualize inflamed tissues and help diagnose conditions such as arthritis, infections, and inflammatory bowel disease. As there are numerous alternative disease diagnostic technologies accessible, the market's expansion might be restricted by their popularity among consumers.

Application Outlook

Based on application, the market is fragmented into diabetes, rheumatoid arthritis, cardiovascular disease, inflammatory bowel disease, and others. The rheumatoid arthritis segment projected a prominent revenue share in the market in 2022. Elevated CRP levels, along with other laboratory tests and clinical evaluations, can aid in diagnosing rheumatoid arthritis, even though no single test can confirm the diagnosis. CRP level reduction over time often indicates that a treatment technique effectively controls RA-related inflammation.

Assay Type Outlook

By assay type, the market is segmented into enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), immunoturbidimetric assays, and others. The enzyme-linked immunosorbent assay (ELISA) segment acquired a substantial revenue share in the market in 2022. The precise concentration of CRP in a sample is measured by ELISA, which produces quantitative data. This enables precise monitoring of changes over time and aids in evaluating disease activity and treatment response by healthcare professionals. Since ELISA assays can be designed to be very specific to CRP, there is a low probability that the test results will be affected by any cross-reactivity with other substances in the blood.

End User Outlook

based on end user, the market is divided into hospitals & clinics, diagnostic laboratories, and others. The diagnostics laboratories segment witnessed a remarkable growth rate in the market in 2022. Diagnostic laboratories are essential in veterinary pain management as they provide the foundation for accurate diagnosis, treatment planning, and ongoing monitoring of pain in animals. Their role in improving the quality of life and welfare of animals cannot be overstated, and they are a valuable resource for veterinarians and pet owners alike.

Regional Outlook

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region registered the highest revenue share in the market. The convenience and rapidity of point-of-care testing are making it a growing trend in the region. Rapid results of POCT for CRP testing can help with rapid diagnosis and therapy. The market in North America is anticipated to be driven by technological advancements that have improved CRP testing's accuracy, efficacy, and affordability. During the forecast period, it is predicted that the market in North America will be driven by the growth in the prevalence of inflammatory diseases unhealthy lifestyles, and the development of new testing kits and solutions for early detection of inflammatory ailments.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Danaher Corporation, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Laboratory Corporation of America Holdings, Randox Laboratories Limited, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Horiba, Ltd., Merck KGaA, and Zoetis, Inc.

Scope of the Study

Market Segments covered in the Report:

By Application

  • Cardiovascular Disease
  • Inflammatory Bowel Disease
  • Rheumatoid Arthritis
  • Diabetes
  • Others

By Assay Type

  • Immunoturbidimetric Assays
  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Chemiluminescence Immunoassay (CLIA)
  • Others

By End User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Laboratory Corporation of America Holdings
  • Randox Laboratories Limited
  • Thermo Fisher Scientific Inc.
  • Quest Diagnostics Incorporated
  • Horiba, Ltd.
  • Merck KGaA
  • Zoetis, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global C-reactive Protein Testing Market, by Application
    • 1.4.2 Global C-reactive Protein Testing Market, by Assay Type
    • 1.4.3 Global C-reactive Protein Testing Market, by End User
    • 1.4.4 Global C-reactive Protein Testing Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter's Five Force Analysis

Chapter 4. Global C-reactive Protein Testing Market by Application

  • 4.1 Global Cardiovascular Disease Market by Region
  • 4.2 Global Inflammatory Bowel Disease Market by Region
  • 4.3 Global Rheumatoid Arthritis Market by Region
  • 4.4 Global Diabetes Market by Region
  • 4.5 Global Others Market by Region

Chapter 5. Global C-reactive Protein Testing Market by Assay Type

  • 5.1 Global Immunoturbidimetric Assays Market by Region
  • 5.2 Global Enzyme-linked Immunosorbent Assay (ELISA) Market by Region
  • 5.3 Global Chemiluminescence Immunoassay (CLIA) Market by Region
  • 5.4 Global Others Market by Region

Chapter 6. Global C-reactive Protein Testing Market by End User

  • 6.1 Global Hospitals & Clinics Market by Region
  • 6.2 Global Diagnostic Laboratories Market by Region
  • 6.3 Global Others Market by Region

Chapter 7. Global C-reactive Protein Testing Market by Region

  • 7.1 North America C-reactive Protein Testing Market
    • 7.1.1 North America C-reactive Protein Testing Market by Application
      • 7.1.1.1 North America Cardiovascular Disease Market by Country
      • 7.1.1.2 North America Inflammatory Bowel Disease Market by Country
      • 7.1.1.3 North America Rheumatoid Arthritis Market by Country
      • 7.1.1.4 North America Diabetes Market by Country
      • 7.1.1.5 North America Others Market by Country
    • 7.1.2 North America C-reactive Protein Testing Market by Assay Type
      • 7.1.2.1 North America Immunoturbidimetric Assays Market by Country
      • 7.1.2.2 North America Enzyme-linked Immunosorbent Assay (ELISA) Market by Country
      • 7.1.2.3 North America Chemiluminescence Immunoassay (CLIA) Market by Country
      • 7.1.2.4 North America Others Market by Country
    • 7.1.3 North America C-reactive Protein Testing Market by End User
      • 7.1.3.1 North America Hospitals & Clinics Market by Country
      • 7.1.3.2 North America Diagnostic Laboratories Market by Country
      • 7.1.3.3 North America Others Market by Country
    • 7.1.4 North America C-reactive Protein Testing Market by Country
      • 7.1.4.1 US C-reactive Protein Testing Market
        • 7.1.4.1.1 US C-reactive Protein Testing Market by Application
        • 7.1.4.1.2 US C-reactive Protein Testing Market by Assay Type
        • 7.1.4.1.3 US C-reactive Protein Testing Market by End User
      • 7.1.4.2 Canada C-reactive Protein Testing Market
        • 7.1.4.2.1 Canada C-reactive Protein Testing Market by Application
        • 7.1.4.2.2 Canada C-reactive Protein Testing Market by Assay Type
        • 7.1.4.2.3 Canada C-reactive Protein Testing Market by End User
      • 7.1.4.3 Mexico C-reactive Protein Testing Market
        • 7.1.4.3.1 Mexico C-reactive Protein Testing Market by Application
        • 7.1.4.3.2 Mexico C-reactive Protein Testing Market by Assay Type
        • 7.1.4.3.3 Mexico C-reactive Protein Testing Market by End User
      • 7.1.4.4 Rest of North America C-reactive Protein Testing Market
        • 7.1.4.4.1 Rest of North America C-reactive Protein Testing Market by Application
        • 7.1.4.4.2 Rest of North America C-reactive Protein Testing Market by Assay Type
        • 7.1.4.4.3 Rest of North America C-reactive Protein Testing Market by End User
  • 7.2 Europe C-reactive Protein Testing Market
    • 7.2.1 Europe C-reactive Protein Testing Market by Application
      • 7.2.1.1 Europe Cardiovascular Disease Market by Country
      • 7.2.1.2 Europe Inflammatory Bowel Disease Market by Country
      • 7.2.1.3 Europe Rheumatoid Arthritis Market by Country
      • 7.2.1.4 Europe Diabetes Market by Country
      • 7.2.1.5 Europe Others Market by Country
    • 7.2.2 Europe C-reactive Protein Testing Market by Assay Type
      • 7.2.2.1 Europe Immunoturbidimetric Assays Market by Country
      • 7.2.2.2 Europe Enzyme-linked Immunosorbent Assay (ELISA) Market by Country
      • 7.2.2.3 Europe Chemiluminescence Immunoassay (CLIA) Market by Country
      • 7.2.2.4 Europe Others Market by Country
    • 7.2.3 Europe C-reactive Protein Testing Market by End User
      • 7.2.3.1 Europe Hospitals & Clinics Market by Country
      • 7.2.3.2 Europe Diagnostic Laboratories Market by Country
      • 7.2.3.3 Europe Others Market by Country
    • 7.2.4 Europe C-reactive Protein Testing Market by Country
      • 7.2.4.1 Germany C-reactive Protein Testing Market
        • 7.2.4.1.1 Germany C-reactive Protein Testing Market by Application
        • 7.2.4.1.2 Germany C-reactive Protein Testing Market by Assay Type
        • 7.2.4.1.3 Germany C-reactive Protein Testing Market by End User
      • 7.2.4.2 UK C-reactive Protein Testing Market
        • 7.2.4.2.1 UK C-reactive Protein Testing Market by Application
        • 7.2.4.2.2 UK C-reactive Protein Testing Market by Assay Type
        • 7.2.4.2.3 UK C-reactive Protein Testing Market by End User
      • 7.2.4.3 France C-reactive Protein Testing Market
        • 7.2.4.3.1 France C-reactive Protein Testing Market by Application
        • 7.2.4.3.2 France C-reactive Protein Testing Market by Assay Type
        • 7.2.4.3.3 France C-reactive Protein Testing Market by End User
      • 7.2.4.4 Russia C-reactive Protein Testing Market
        • 7.2.4.4.1 Russia C-reactive Protein Testing Market by Application
        • 7.2.4.4.2 Russia C-reactive Protein Testing Market by Assay Type
        • 7.2.4.4.3 Russia C-reactive Protein Testing Market by End User
      • 7.2.4.5 Spain C-reactive Protein Testing Market
        • 7.2.4.5.1 Spain C-reactive Protein Testing Market by Application
        • 7.2.4.5.2 Spain C-reactive Protein Testing Market by Assay Type
        • 7.2.4.5.3 Spain C-reactive Protein Testing Market by End User
      • 7.2.4.6 Italy C-reactive Protein Testing Market
        • 7.2.4.6.1 Italy C-reactive Protein Testing Market by Application
        • 7.2.4.6.2 Italy C-reactive Protein Testing Market by Assay Type
        • 7.2.4.6.3 Italy C-reactive Protein Testing Market by End User
      • 7.2.4.7 Rest of Europe C-reactive Protein Testing Market
        • 7.2.4.7.1 Rest of Europe C-reactive Protein Testing Market by Application
        • 7.2.4.7.2 Rest of Europe C-reactive Protein Testing Market by Assay Type
        • 7.2.4.7.3 Rest of Europe C-reactive Protein Testing Market by End User
  • 7.3 Asia Pacific C-reactive Protein Testing Market
    • 7.3.1 Asia Pacific C-reactive Protein Testing Market by Application
      • 7.3.1.1 Asia Pacific Cardiovascular Disease Market by Country
      • 7.3.1.2 Asia Pacific Inflammatory Bowel Disease Market by Country
      • 7.3.1.3 Asia Pacific Rheumatoid Arthritis Market by Country
      • 7.3.1.4 Asia Pacific Diabetes Market by Country
      • 7.3.1.5 Asia Pacific Others Market by Country
    • 7.3.2 Asia Pacific C-reactive Protein Testing Market by Assay Type
      • 7.3.2.1 Asia Pacific Immunoturbidimetric Assays Market by Country
      • 7.3.2.2 Asia Pacific Enzyme-linked Immunosorbent Assay (ELISA) Market by Country
      • 7.3.2.3 Asia Pacific Chemiluminescence Immunoassay (CLIA) Market by Country
      • 7.3.2.4 Asia Pacific Others Market by Country
    • 7.3.3 Asia Pacific C-reactive Protein Testing Market by End User
      • 7.3.3.1 Asia Pacific Hospitals & Clinics Market by Country
      • 7.3.3.2 Asia Pacific Diagnostic Laboratories Market by Country
      • 7.3.3.3 Asia Pacific Others Market by Country
    • 7.3.4 Asia Pacific C-reactive Protein Testing Market by Country
      • 7.3.4.1 China C-reactive Protein Testing Market
        • 7.3.4.1.1 China C-reactive Protein Testing Market by Application
        • 7.3.4.1.2 China C-reactive Protein Testing Market by Assay Type
        • 7.3.4.1.3 China C-reactive Protein Testing Market by End User
      • 7.3.4.2 Japan C-reactive Protein Testing Market
        • 7.3.4.2.1 Japan C-reactive Protein Testing Market by Application
        • 7.3.4.2.2 Japan C-reactive Protein Testing Market by Assay Type
        • 7.3.4.2.3 Japan C-reactive Protein Testing Market by End User
      • 7.3.4.3 India C-reactive Protein Testing Market
        • 7.3.4.3.1 India C-reactive Protein Testing Market by Application
        • 7.3.4.3.2 India C-reactive Protein Testing Market by Assay Type
        • 7.3.4.3.3 India C-reactive Protein Testing Market by End User
      • 7.3.4.4 South Korea C-reactive Protein Testing Market
        • 7.3.4.4.1 South Korea C-reactive Protein Testing Market by Application
        • 7.3.4.4.2 South Korea C-reactive Protein Testing Market by Assay Type
        • 7.3.4.4.3 South Korea C-reactive Protein Testing Market by End User
      • 7.3.4.5 Singapore C-reactive Protein Testing Market
        • 7.3.4.5.1 Singapore C-reactive Protein Testing Market by Application
        • 7.3.4.5.2 Singapore C-reactive Protein Testing Market by Assay Type
        • 7.3.4.5.3 Singapore C-reactive Protein Testing Market by End User
      • 7.3.4.6 Malaysia C-reactive Protein Testing Market
        • 7.3.4.6.1 Malaysia C-reactive Protein Testing Market by Application
        • 7.3.4.6.2 Malaysia C-reactive Protein Testing Market by Assay Type
        • 7.3.4.6.3 Malaysia C-reactive Protein Testing Market by End User
      • 7.3.4.7 Rest of Asia Pacific C-reactive Protein Testing Market
        • 7.3.4.7.1 Rest of Asia Pacific C-reactive Protein Testing Market by Application
        • 7.3.4.7.2 Rest of Asia Pacific C-reactive Protein Testing Market by Assay Type
        • 7.3.4.7.3 Rest of Asia Pacific C-reactive Protein Testing Market by End User
  • 7.4 LAMEA C-reactive Protein Testing Market
    • 7.4.1 LAMEA C-reactive Protein Testing Market by Application
      • 7.4.1.1 LAMEA Cardiovascular Disease Market by Country
      • 7.4.1.2 LAMEA Inflammatory Bowel Disease Market by Country
      • 7.4.1.3 LAMEA Rheumatoid Arthritis Market by Country
      • 7.4.1.4 LAMEA Diabetes Market by Country
      • 7.4.1.5 LAMEA Others Market by Country
    • 7.4.2 LAMEA C-reactive Protein Testing Market by Assay Type
      • 7.4.2.1 LAMEA Immunoturbidimetric Assays Market by Country
      • 7.4.2.2 LAMEA Enzyme-linked Immunosorbent Assay (ELISA) Market by Country
      • 7.4.2.3 LAMEA Chemiluminescence Immunoassay (CLIA) Market by Country
      • 7.4.2.4 LAMEA Others Market by Country
    • 7.4.3 LAMEA C-reactive Protein Testing Market by End User
      • 7.4.3.1 LAMEA Hospitals & Clinics Market by Country
      • 7.4.3.2 LAMEA Diagnostic Laboratories Market by Country
      • 7.4.3.3 LAMEA Others Market by Country
    • 7.4.4 LAMEA C-reactive Protein Testing Market by Country
      • 7.4.4.1 Brazil C-reactive Protein Testing Market
        • 7.4.4.1.1 Brazil C-reactive Protein Testing Market by Application
        • 7.4.4.1.2 Brazil C-reactive Protein Testing Market by Assay Type
        • 7.4.4.1.3 Brazil C-reactive Protein Testing Market by End User
      • 7.4.4.2 Argentina C-reactive Protein Testing Market
        • 7.4.4.2.1 Argentina C-reactive Protein Testing Market by Application
        • 7.4.4.2.2 Argentina C-reactive Protein Testing Market by Assay Type
        • 7.4.4.2.3 Argentina C-reactive Protein Testing Market by End User
      • 7.4.4.3 UAE C-reactive Protein Testing Market
        • 7.4.4.3.1 UAE C-reactive Protein Testing Market by Application
        • 7.4.4.3.2 UAE C-reactive Protein Testing Market by Assay Type
        • 7.4.4.3.3 UAE C-reactive Protein Testing Market by End User
      • 7.4.4.4 Saudi Arabia C-reactive Protein Testing Market
        • 7.4.4.4.1 Saudi Arabia C-reactive Protein Testing Market by Application
        • 7.4.4.4.2 Saudi Arabia C-reactive Protein Testing Market by Assay Type
        • 7.4.4.4.3 Saudi Arabia C-reactive Protein Testing Market by End User
      • 7.4.4.5 South Africa C-reactive Protein Testing Market
        • 7.4.4.5.1 South Africa C-reactive Protein Testing Market by Application
        • 7.4.4.5.2 South Africa C-reactive Protein Testing Market by Assay Type
        • 7.4.4.5.3 South Africa C-reactive Protein Testing Market by End User
      • 7.4.4.6 Nigeria C-reactive Protein Testing Market
        • 7.4.4.6.1 Nigeria C-reactive Protein Testing Market by Application
        • 7.4.4.6.2 Nigeria C-reactive Protein Testing Market by Assay Type
        • 7.4.4.6.3 Nigeria C-reactive Protein Testing Market by End User
      • 7.4.4.7 Rest of LAMEA C-reactive Protein Testing Market
        • 7.4.4.7.1 Rest of LAMEA C-reactive Protein Testing Market by Application
        • 7.4.4.7.2 Rest of LAMEA C-reactive Protein Testing Market by Assay Type
        • 7.4.4.7.3 Rest of LAMEA C-reactive Protein Testing Market by End User

Chapter 8. Company Profiles

  • 8.1 Danaher Corporation
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 SWOT Analysis
  • 8.2 F. Hoffmann-La Roche Ltd.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 SWOT Analysis
  • 8.3 Abbott Laboratories
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 SWOT Analysis
  • 8.4 Thermo Fisher Scientific, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expenses
    • 8.4.5 SWOT Analysis
  • 8.5 Horiba Ltd.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Regional & Segmental Analysis
    • 8.5.4 Research & Development Expenses
    • 8.5.5 SWOT Analysis
  • 8.6 Randox Laboratories Limited
    • 8.6.1 Company Overview
    • 8.6.2 SWOT Analysis
  • 8.7 Zoetis, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Regional Analysis
    • 8.7.4 Research & Development Expense
    • 8.7.5 SWOT Analysis
  • 8.8 Quest Diagnostics Incorporated
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental Analysis
    • 8.8.4 SWOT Analysis
  • 8.9 Laboratory Corporation of America Holdings
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental Analysis
    • 8.9.4 SWOT Analysis
  • 8.10. Merck KGaA
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Segmental and Regional Analysis
    • 8.10.4 Research & Development Expense
    • 8.10.5 SWOT Analysis

Chapter 9. Winning Imperative for C-Reactive Protein Testing Market

LIST OF TABLES

  • TABLE 1 Global C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 2 Global C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 3 Global C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 4 Global C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 5 Global Cardiovascular Disease Market by Region, 2019 - 2022, USD Million
  • TABLE 6 Global Cardiovascular Disease Market by Region, 2023 - 2030, USD Million
  • TABLE 7 Global Inflammatory Bowel Disease Market by Region, 2019 - 2022, USD Million
  • TABLE 8 Global Inflammatory Bowel Disease Market by Region, 2023 - 2030, USD Million
  • TABLE 9 Global Rheumatoid Arthritis Market by Region, 2019 - 2022, USD Million
  • TABLE 10 Global Rheumatoid Arthritis Market by Region, 2023 - 2030, USD Million
  • TABLE 11 Global Diabetes Market by Region, 2019 - 2022, USD Million
  • TABLE 12 Global Diabetes Market by Region, 2023 - 2030, USD Million
  • TABLE 13 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 14 Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 15 Global C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 16 Global C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 17 Global Immunoturbidimetric Assays Market by Region, 2019 - 2022, USD Million
  • TABLE 18 Global Immunoturbidimetric Assays Market by Region, 2023 - 2030, USD Million
  • TABLE 19 Global Enzyme-linked Immunosorbent Assay (ELISA) Market by Region, 2019 - 2022, USD Million
  • TABLE 20 Global Enzyme-linked Immunosorbent Assay (ELISA) Market by Region, 2023 - 2030, USD Million
  • TABLE 21 Global Chemiluminescence Immunoassay (CLIA) Market by Region, 2019 - 2022, USD Million
  • TABLE 22 Global Chemiluminescence Immunoassay (CLIA) Market by Region, 2023 - 2030, USD Million
  • TABLE 23 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 24 Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 25 Global C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 26 Global C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 27 Global Hospitals & Clinics Market by Region, 2019 - 2022, USD Million
  • TABLE 28 Global Hospitals & Clinics Market by Region, 2023 - 2030, USD Million
  • TABLE 29 Global Diagnostic Laboratories Market by Region, 2019 - 2022, USD Million
  • TABLE 30 Global Diagnostic Laboratories Market by Region, 2023 - 2030, USD Million
  • TABLE 31 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 32 Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 33 Global C-reactive Protein Testing Market by Region, 2019 - 2022, USD Million
  • TABLE 34 Global C-reactive Protein Testing Market by Region, 2023 - 2030, USD Million
  • TABLE 35 North America C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 36 North America C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 37 North America C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 38 North America C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 39 North America Cardiovascular Disease Market by Country, 2019 - 2022, USD Million
  • TABLE 40 North America Cardiovascular Disease Market by Country, 2023 - 2030, USD Million
  • TABLE 41 North America Inflammatory Bowel Disease Market by Country, 2019 - 2022, USD Million
  • TABLE 42 North America Inflammatory Bowel Disease Market by Country, 2023 - 2030, USD Million
  • TABLE 43 North America Rheumatoid Arthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 44 North America Rheumatoid Arthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 45 North America Diabetes Market by Country, 2019 - 2022, USD Million
  • TABLE 46 North America Diabetes Market by Country, 2023 - 2030, USD Million
  • TABLE 47 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 48 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 49 North America C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 50 North America C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 51 North America Immunoturbidimetric Assays Market by Country, 2019 - 2022, USD Million
  • TABLE 52 North America Immunoturbidimetric Assays Market by Country, 2023 - 2030, USD Million
  • TABLE 53 North America Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2019 - 2022, USD Million
  • TABLE 54 North America Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2023 - 2030, USD Million
  • TABLE 55 North America Chemiluminescence Immunoassay (CLIA) Market by Country, 2019 - 2022, USD Million
  • TABLE 56 North America Chemiluminescence Immunoassay (CLIA) Market by Country, 2023 - 2030, USD Million
  • TABLE 57 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 58 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 59 North America C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 60 North America C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 61 North America Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 62 North America Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 63 North America Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
  • TABLE 64 North America Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
  • TABLE 65 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 66 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 67 North America C-reactive Protein Testing Market by Country, 2019 - 2022, USD Million
  • TABLE 68 North America C-reactive Protein Testing Market by Country, 2023 - 2030, USD Million
  • TABLE 69 US C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 70 US C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 71 US C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 72 US C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 73 US C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 74 US C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 75 US C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 76 US C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 77 Canada C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 78 Canada C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 79 Canada C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 80 Canada C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 81 Canada C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 82 Canada C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 83 Canada C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 84 Canada C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 85 Mexico C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 86 Mexico C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 87 Mexico C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 88 Mexico C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 89 Mexico C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 90 Mexico C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 91 Mexico C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 92 Mexico C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 93 Rest of North America C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 94 Rest of North America C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 95 Rest of North America C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 96 Rest of North America C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 97 Rest of North America C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 98 Rest of North America C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 99 Rest of North America C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 100 Rest of North America C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 101 Europe C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 102 Europe C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 103 Europe C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 104 Europe C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 105 Europe Cardiovascular Disease Market by Country, 2019 - 2022, USD Million
  • TABLE 106 Europe Cardiovascular Disease Market by Country, 2023 - 2030, USD Million
  • TABLE 107 Europe Inflammatory Bowel Disease Market by Country, 2019 - 2022, USD Million
  • TABLE 108 Europe Inflammatory Bowel Disease Market by Country, 2023 - 2030, USD Million
  • TABLE 109 Europe Rheumatoid Arthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 110 Europe Rheumatoid Arthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 111 Europe Diabetes Market by Country, 2019 - 2022, USD Million
  • TABLE 112 Europe Diabetes Market by Country, 2023 - 2030, USD Million
  • TABLE 113 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 114 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 115 Europe C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 116 Europe C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 117 Europe Immunoturbidimetric Assays Market by Country, 2019 - 2022, USD Million
  • TABLE 118 Europe Immunoturbidimetric Assays Market by Country, 2023 - 2030, USD Million
  • TABLE 119 Europe Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2019 - 2022, USD Million
  • TABLE 120 Europe Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2023 - 2030, USD Million
  • TABLE 121 Europe Chemiluminescence Immunoassay (CLIA) Market by Country, 2019 - 2022, USD Million
  • TABLE 122 Europe Chemiluminescence Immunoassay (CLIA) Market by Country, 2023 - 2030, USD Million
  • TABLE 123 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 124 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 125 Europe C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 126 Europe C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 127 Europe Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 128 Europe Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 129 Europe Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
  • TABLE 130 Europe Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
  • TABLE 131 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 132 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 133 Europe C-reactive Protein Testing Market by Country, 2019 - 2022, USD Million
  • TABLE 134 Europe C-reactive Protein Testing Market by Country, 2023 - 2030, USD Million
  • TABLE 135 Germany C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 136 Germany C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 137 Germany C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 138 Germany C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 139 Germany C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 140 Germany C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 141 Germany C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 142 Germany C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 143 UK C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 144 UK C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 145 UK C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 146 UK C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 147 UK C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 148 UK C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 149 UK C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 150 UK C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 151 France C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 152 France C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 153 France C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 154 France C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 155 France C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 156 France C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 157 France C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 158 France C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 159 Russia C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 160 Russia C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 161 Russia C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 162 Russia C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 163 Russia C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 164 Russia C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 165 Russia C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 166 Russia C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 167 Spain C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 168 Spain C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 169 Spain C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 170 Spain C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 171 Spain C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 172 Spain C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 173 Spain C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 174 Spain C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 175 Italy C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 176 Italy C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 177 Italy C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 178 Italy C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 179 Italy C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 180 Italy C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 181 Italy C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 182 Italy C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 183 Rest of Europe C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 184 Rest of Europe C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 185 Rest of Europe C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 186 Rest of Europe C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 187 Rest of Europe C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 188 Rest of Europe C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 189 Rest of Europe C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 190 Rest of Europe C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 191 Asia Pacific C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 192 Asia Pacific C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 193 Asia Pacific C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 194 Asia Pacific C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 195 Asia Pacific Cardiovascular Disease Market by Country, 2019 - 2022, USD Million
  • TABLE 196 Asia Pacific Cardiovascular Disease Market by Country, 2023 - 2030, USD Million
  • TABLE 197 Asia Pacific Inflammatory Bowel Disease Market by Country, 2019 - 2022, USD Million
  • TABLE 198 Asia Pacific Inflammatory Bowel Disease Market by Country, 2023 - 2030, USD Million
  • TABLE 199 Asia Pacific Rheumatoid Arthritis Market by Country, 2019 - 2022, USD Million
  • TABLE 200 Asia Pacific Rheumatoid Arthritis Market by Country, 2023 - 2030, USD Million
  • TABLE 201 Asia Pacific Diabetes Market by Country, 2019 - 2022, USD Million
  • TABLE 202 Asia Pacific Diabetes Market by Country, 2023 - 2030, USD Million
  • TABLE 203 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 204 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 205 Asia Pacific C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 206 Asia Pacific C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 207 Asia Pacific Immunoturbidimetric Assays Market by Country, 2019 - 2022, USD Million
  • TABLE 208 Asia Pacific Immunoturbidimetric Assays Market by Country, 2023 - 2030, USD Million
  • TABLE 209 Asia Pacific Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2019 - 2022, USD Million
  • TABLE 210 Asia Pacific Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2023 - 2030, USD Million
  • TABLE 211 Asia Pacific Chemiluminescence Immunoassay (CLIA) Market by Country, 2019 - 2022, USD Million
  • TABLE 212 Asia Pacific Chemiluminescence Immunoassay (CLIA) Market by Country, 2023 - 2030, USD Million
  • TABLE 213 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 214 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 215 Asia Pacific C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 216 Asia Pacific C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 217 Asia Pacific Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 218 Asia Pacific Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 219 Asia Pacific Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
  • TABLE 220 Asia Pacific Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
  • TABLE 221 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 222 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 223 Asia Pacific C-reactive Protein Testing Market by Country, 2019 - 2022, USD Million
  • TABLE 224 Asia Pacific C-reactive Protein Testing Market by Country, 2023 - 2030, USD Million
  • TABLE 225 China C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 226 China C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 227 China C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 228 China C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 229 China C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 230 China C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 231 China C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 232 China C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 233 Japan C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 234 Japan C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 235 Japan C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 236 Japan C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 237 Japan C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 238 Japan C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 239 Japan C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 240 Japan C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 241 India C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 242 India C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 243 India C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 244 India C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 245 India C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 246 India C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 247 India C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 248 India C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 249 South Korea C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 250 South Korea C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 251 South Korea C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 252 South Korea C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 253 South Korea C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 254 South Korea C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 255 South Korea C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 256 South Korea C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 257 Singapore C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 258 Singapore C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 259 Singapore C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 260 Singapore C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 261 Singapore C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 262 Singapore C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 263 Singapore C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 264 Singapore C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 265 Malaysia C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 266 Malaysia C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 267 Malaysia C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 268 Malaysia C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 269 Malaysia C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 270 Malaysia C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 271 Malaysia C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 272 Malaysia C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
  • TABLE 273 Rest of Asia Pacific C-reactive Protein Testing Market, 2019 - 2022, USD Million
  • TABLE 274 Rest of Asia Pacific C-reactive Protein Testing Market, 2023 - 2030, USD Million
  • TABLE 275 Rest of Asia Pacific C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
  • TABLE 276 Rest of Asia Pacific C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
  • TABLE 277 Rest of Asia Pacific C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
  • TABLE 278 Rest of Asia Pacific C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
  • TABLE 279 Rest of Asia Pacific C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
  • TABLE 280 Rest of Asia Pacific C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million